Three-way crossover BABE Studies [Design Issues]

posted by acfalcao – 2007-09-17 00:34 (5741 d 20:08 ago) – Posting: # 1082
Views: 31,444

Dear All

My name is Amilcar Falcão and I am professor at the University of Coimbra, Portugal. I am looking for help regarding the execution and interpretation of three-way cross-over bioequivalence trials (for academic purposes).

I would like to have an example (explicit) where a three-way crossover study is appropriately analysed. Namely, I would like to know what kind of ANOVA should be performed and how the 90%CI should be calculated for the different combinations of study formulations (i.e. A vs B and A vs C). Perhaps this is a naive question, but in fact I am trying to look for it in literature and I have seen different approaches always without the adopted statistical pathway. Therefore, I would like to be sure regarding the correct way to deal with.

I strongly appreciate if you could help me about this matter.

Thank you for your attention.

Best regards; :-)

Amílcar Falcão
Laboratory of Pharmacology
Faculty of Pharmacy
University of Coimbra
Coimbra - Portugal

Complete thread:

UA Flag
Activity
 Admin contact
22,618 posts in 4,741 threads, 1,611 registered users;
12 visitors (0 registered, 12 guests [including 6 identified bots]).
Forum time: 20:43 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5